Board of Directors

Navidea's management team and board of directors are leaders in research, development and commercialization of diagnostic agents and therapeutics.

Eric K. Rowinsky, M.D.
Navidea Chairman of the Board
Executive Chairman and President, Rgenix, Inc.

Tony Fiorino, M.D., Ph.D.
President and CEO
Triumvira Immunologics

Michael M. Goldberg, M.D.
President and Chief Executive Officer
Navidea Biopharmaceuticals

Mark I. Greene, M.D., Ph.D. FRCP
Director of the Division of Immunology
University of Pennsylvania School of Medicine

Michael Rice
Founding Partner
LifeSci Advisors, LLC and LifeSci Capital, LLC